ibrutinib

Bruton agammaglobulinemia tyrosine kinase ; Mus musculus







79 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34662393 Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia. 2022 Feb 10 3
2 34706199 CD38-mediated Inhibition of Bruton's Tyrosine Kinase in Macrophages Prevents Endotoxemic Lung Injury. 2022 Feb 2
3 34897650 Bruton's TK regulates myeloid cell recruitment during acute inflammation. 2022 Jun 1
4 35595730 Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia. 2022 May 20 1
5 32139435 Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice. 2021 Apr 1 4
6 32855532 Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma. 2021 May 2
7 33168411 Bruton's tyrosine kinase inhibition attenuates oxidative stress in systemic immune cells and renal compartment during sepsis-induced acute kidney injury in mice. 2021 Jan 1
8 33561536 Geniposide protects depression through BTK/JAK2/STAT1 signaling pathway in lipopolysaccharide-induced depressive mice. 2021 May 2
9 33669187 BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma. 2021 Feb 16 2
10 33746983 Transcriptomic Analysis of Inflammatory Cardiomyopathy Identifies Molecular Signatures of Disease and Informs in silico Prediction of a Network-Based Rationale for Therapy. 2021 1
11 33831782 NLRP3 inflammasome and bruton tyrosine kinase inhibition interferes with upregulated platelet aggregation and in vitro thrombus formation in sickle cell mice. 2021 May 28 1
12 33851691 Tirabrutinib hydrochloride for B-cell lymphomas. 2021 Apr 2
13 34031271 Ibrutinib reduces neutrophil infiltration, preserves neural tissue and enhances locomotor recovery in mouse contusion model of spinal cord injury. 2021 Sep 30 1
14 34112701 Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T Cells. 2021 Jun 10 1
15 34605340 Ibrutinib ameliorates cerebral ischemia/reperfusion injury through autophagy activation and PI3K/Akt/mTOR signaling pathway in diabetic mice. 2021 Dec 1
16 34726066 Distinct Effects of Ibrutinib and Acalabrutinib on Mouse Atrial and Sinoatrial Node Electrophysiology and Arrhythmogenesis. 2021 Nov 16 1
17 34895246 Bruton's tyrosine kinase drives neuroinflammation and anxiogenic behavior in mouse models of stress. 2021 Dec 11 2
18 31582534 Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma. 2020 Feb 3
19 31736210 Amelioration of age-related brain function decline by Bruton's tyrosine kinase inhibition. 2020 Jan 1
20 31895698 Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis. 2020 Apr 1 2
21 32025027 Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells. 2020 Mar 2
22 32093809 A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma. 2020 Sep 1 1
23 32272741 Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant. 2020 Apr 7 2
24 32319217 SWATH-Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G-CSFR Signaling. 2020 Sep 1
25 32608058 Inhibition of Bruton's TK regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation. 2020 Oct 2
26 32790160 ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer. 2020 Aug 2
27 33092403 Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase. 2020 Dec 22 2
28 33162995 X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure. 2020 3
29 30646846 Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia. 2019 Jan 15 4
30 30819907 p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape. 2019 Oct 1
31 31247078 B lymphocytes inactivation by Ibrutinib limits endometriosis progression in mice. 2019 Jul 8 4
32 31364164 A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant BtkC481S mutation in B-cell malignancies. 2019 Dec 1
33 31365830 IL-6/p-BTK/p-ERK signaling mediates calcium phosphate-induced pruritus. 2019 Nov 2
34 31478435 The Development and Applications of a Dual Optical Imaging System for Studying Glioma Stem Cells. 2019 Jan-Dec 1
35 31505252 Inhibition of Bruton's tyrosine kinase and IL-2 inducible T-cell kinase suppresses both neutrophilic and eosinophilic airway inflammation in a cockroach allergen extract-induced mixed granulocytic mouse model of asthma using preventative and therapeutic strategy. 2019 Oct 2
36 31508518 Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model. 2019 Aug 1
37 31552054 Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice. 2019 3
38 29398709 Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner. 2018 Apr 1
39 29483220 p110α Inhibition Overcomes Stromal Cell-Mediated Ibrutinib Resistance in Mantle Cell Lymphoma. 2018 May 2
40 29516781 Inhibiting Bruton's tyrosine kinase rescues mice from lethal influenza-induced acute lung injury. 2018 Jul 1 1
41 29567142 Molecular characterization and function analysis of grouper (Epinephelus coioides) Bruton's tyrosine kinase BTK. 2018 Jun 1
42 30013190 Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma. 2018 Nov 1
43 30231870 Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice. 2018 Sep 19 2
44 30237801 Distinct Roles for Bruton's Tyrosine Kinase in B Cell Immune Synapse Formation. 2018 1
45 30247919 P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability. 2018 Nov 5 6
46 30290988 Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk. 2018 Nov 15 1
47 30333099 The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase. 2018 Oct 23 1
48 28031181 Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK. 2017 Mar 2 3
49 28275136 Distinct and Overlapping Functions of TEC Kinase and BTK in B Cell Receptor Signaling. 2017 Apr 15 1
50 28368423 Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition. 2017 Aug 10 1